Form 4 for YARW Yarrow Bioscience, Inc.
Accepted 2023-12-15 00:00:00 ET · period of report 2023-12-13 · accession 0001209191-23-058818 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-12-15 | 2023-12-13 | YARW | Stuart Iain | CSO | A - Grant | $0.00 | +62.5K | 71.6K | +690% | $0 |
| D | 2023-12-15 | 2023-12-13 | YARW | Stuart Iain | CSO | A - Grant | $0.00 | +62.5K | 62.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-13 | A | A | 62,500 | $0.00 | 71,555 | D | — | — | (F2) The shares underlying the RSU vest over a period of 4 years. 25% of the shares subject to the award will vest on December 31, 2024 and 6.25% of the shares will vest on the last day of each quarter thereafter. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date. (F1) Grant to the Reporting Person of a restricted stock unit ("RSU") award. Each RSU represents a contingent right to receive one share of common stock of the Issuer. |
| 2 | Derivative | Stock Option (right to buy) | 2023-12-13 | A | A | 62,500 | $0.00 | 62,500 | D | $2.70 · — to 2033-12-12 | 62,500 Common Stock | (F3) The shares subject to the option vest over a period of 4 years. 25% of the shares subject to the option will vest on December 31, 2024 and 6.25% of the shares will vest on the last day of each quarter thereafter. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date. |